Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Riyadh airport to designate terminals for flights from October 25
Around 1,200 Palestinians displaced in Hebron as Israel begins military operation
Jordan tightens security after deadly church attack kills nine
Houthi missile shrapnel falls in Saudi Arabia's Jeddah, Taif, Rabigh after interceptions
Violence flares in Paris after largely peaceful protests across France
